video thumbnail

Cancer Immunotherapy- The New 4th Arm

Duration: 29:05

Write A New Comment

2 Comments

...

mhundley@*.com

Jan 09 2024, 6:55 pm

Dr Murphy is a superb communicator! He is precise in his answers based on his actual experience and understanding of verified science! He is not prone to hyperbole. Thank you both.

...

drrasheedk@*.com

Dec 06 2023, 11:50 am

Awesome another lecture.Thank you both.

Dr. William Murphy Distinguished Prof., Vice Chair of Research for Dermatology and Internal Medicine departments discusses cancer immunotherapy. The following topics are discussed:
The new trends in this area and the mechanisms involved are being researched.
Cost, risk, success, and failure of various methods in this area.
Passive immunotherapy vs active immunotherapy is discussed.
CAR-T cell-related mechanics are discussed.

Brief bio of Dr. Murphy:
My research for the past 30 years has centered on translational studies involving modeling cancer-immune system interactions starting with my earlier studies on NK cells and HSCT in mouse models and later at the National Cancer Institute on their role in cancer immunotherapy which then expanded to issues in immunotherapy in general.

Dr. William J. Murphy, Ph.D. for UC Davis Health
https://health.ucdavis.edu/team/search/1226/william-murphy---cancer---dermatology---hematology-oncology---pathology---dermatopathology-sacramento

  1. Grasp cancer fundamentals for a comprehensive foundation.
  2. Explore cancer immunotherapy principles and applications.
  3. Examine immunotherapy's specificity in targeting cancer cells.
  4. Identify and understand various immunotherapy types.
  5. Recognize drawbacks and limitations of immunotherapy.
  6. Investigate checkpoint immunotherapy's role in immune modulation.
  7. Assess the efficacy of immunotherapy in cancer treatment outcomes.

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

  • Prof. Dr. William Murphy

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Prof. Dr. William Murphy Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Hematology and Oncology

Related Videos